Medication-related visits to the emergency department: A prospective study

Annals of Pharmacotherapy

Volumn 33, Issue 12, 1999, Pages 1252-1257

  Tafreshi, Mohammad J ^a   Melby, Michael J ^b   Kaback, Keith R ^c   Nord, Teresa C ^c  

^a MIDWESTERN UNIVERSITY   (United States)

^b Tucson Med Center   (United States)

^c NONE

Author keywords

Emergency department; Medication related visits

Indexed keywords

CARDIOVASCULAR AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; DRUG INDUCED DISEASE; DRUG MONITORING; EMERGENCY TREATMENT; FEMALE; HEALTH CARE COST; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PATIENT EDUCATION; PRIORITY JOURNAL;

EID: 0033396248     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.19062     Document Type: Article

References (14)

1. Jankel CA, Fitterman LK. Epidemiology of drug-drug interactions as a cause of hospital admissions. Drug Saf 1993;9:51-9.
2. Ibanez L, Laporte JR, Carne X. Adverse drug reactions leading to hospital admissions. Drug Saf 1991;6:450-9.
3. Dennehy CE, Kishi DT, Louie C. Drug-related illness in emergency department patients. Am J Health-Syst Pharm 1996;53:1422-6.
4. Prince BS, Goetz CM, Rihn TL, Olsky M. Drug-related emergency department visits and hospital admissions. Am J Hosp Pharm 1992;49: 1696-700.
5. Bates DW, Cullen DJ, Laird N, Petersen LA, Small SD, Servi D, et al. Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group. JAMA 1995; 274:29-34.
6. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients. JAMA 1998;279:1200-5.
7. Lesar TS, Lomaestro BM, Pohl H. Medication prescribing errors in a teaching hospital. A 9-year exprience. Arch Intern Med 1997;157:1569-76.
8. Cullen DJ, Sweitzer BJ, Bates DW, Burdick E, Edmondson A, Leape LL. Preventable adverse drug events in hospitalized patients: a comparative study of intensive care and general care units. Crit Care Med 1997; 25:1289-97.
9. Manasse HR Jr. Medication use in an imperfect world: drug misadventuring as an issue of public policy, Part 1. Am J Hosp Pharm 1989;46: 929-44.
10. Johnson JA, Bootman JL. Drug-related morbidity and mortality. A cost of illness model. Arch Intern Med 1995;155:1949-56.
11. Bootman JL, Harrison DL, Cox E. The health care cost of drug-related morbidity and mortality in nursing facilities. Arch Intern Med 1997;157: 2089-96.
12. Section 1: Treatment of patients. Medication use. In: Accreditation manual for hospitals. Oakbrook Terrace, IL: Joint Commission on Accreditation of Healthcare Organizations, 1994:1-25.
13. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.
14. Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm 1990;47:533-43.